← Back to feed

Abingdon Health

ABDX · AIM · Health Care · mcap £29m today

All announcements

All RNS · 37 Key events · 26

29 Sep 26

UKAS ISO/IEC 17025 accreditation

York, UK and Madison, WI, USA, 29 September 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and provider of regulatory services for rapid diagnostic tests and med-tech, announces that Abingdon...
RNS 9795290 ↗
25 Sep 26

Official opening of manufacturing hub in the US

Official opening of manufacturing hub in the US
RNS 9790315 ↗
08 Sep 26

Shareholder open day

York, UK and Madison, WI, USA, 8 September 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces that it will hold an Open...
RNS 9759946 ↗
29 Jul 26

Trading update

31% increase in full year revenues and progression to EBITDA profitability in H2
RNS 9692307 ↗
29 May 26

Presentation at Mello2026

York, UK and Madison, WI, USA, 29 May 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces that Executive Chairman, Chris...
RNS 9590954 ↗
27 May 26

US tax credit agreement

York, UK and Madison, WI, USA, 27 May 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces that its US subsidiary, Abingdon...
RNS 9586384 ↗
19 May 26

Earn-out Consideration and Issue of Equity

York, UK and Madison, WI, USA, 19 May 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces that the earn-out conditions in...
RNS 9574290 ↗
11 May 26

Launch of LVOne Stroke Test by UpFront Diagnostics

UK Launch of LVOne Stroke Triage Test by UpFront Diagnostics
RNS 9560488 ↗
06 May 26

Update on Partnership with 4TEEN4 Pharmaceuticals

York, UK and Madison, WI, USA, 6 May 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, provides an update on its partnership with...
RNS 9553666 ↗
15 Apr 26

EMI Share Option Scheme

15 April 2026: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces that it has allocated a total of 3,096,000 shares options under its...
RNS 9520463 ↗
14 Apr 26

Trading to commence on the OTCQB in the US

Trading to commence on the OTCQB Venture Market in the US
RNS 9518075 ↗
30 Mar 26

£4.8m contracts awarded

£4.8m contracts awarded for development of multiplex lateral flow systems
RNS 9496982 ↗
17 Mar 26

Half-year Results

45% revenue growth, H2 to be profitable and cash flow positive, confident outlook for FY27
RNS 9476935 ↗
12 Mar 26

$2.5m Contract for clinical self-test development

$2.5m Contract Award for development of clinical self-test
RNS 9470255 ↗
10 Mar 26

Trading on the OTCQB Venture Market in the US

Trading on the OTCQB Venture Market in the US
RNS 9465865 ↗
15 Jan 26

Trading Update

15 January 2026: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, provides its half-year trading update for the six months ended 31 December 2025.
RNS 9354615 ↗
15 Jan 26

Appointment of NOMAD & Corporate Broker

15 January 2026: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces the appointment of Cavendish Capital Markets Limited as sole Corporate...
RNS 9354496 ↗
18 Dec 25

European patent for AppDx® smartphone reader

European patent for AppDx® lateral flow smartphone reader
RNS 9305038 ↗
04 Dec 25

Vesting and Award of Options under LTIP

York, UK 4 December 2025: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces updates, under the terms of the existing Long Term Incentive Plan...
RNS 9274769 ↗
11 Nov 25

Final Results

Final Results for the financial year ended 30 June 2025
RNS 9224976 ↗
10 Nov 25

C.US$2m multiplex diagnostic test contract win

Development, scale-up and technical transfer for a semi-quantitative, multiplex lateral flow test system
RNS 9222121 ↗
06 Nov 25

Launch of seaweed-based lateral flow housings

Alternative to standard plastic housings to reduce plastic waste from LFTs
RNS 9215637 ↗
17 Oct 25

Result of Retail Offer

TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN TO THEM IN THE COMPANY'S ANNOUNCEMENT RELEASED ON 13 OCTOBER 2025 AT 5:04PM.
RNS 9176733 ↗
14 Oct 25

Launch of Retail Offer

Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, announces a retail offer via BookBuild (the "Retail Offer") of new Ordinary Shares ("Ordinary...
RNS 9169436 ↗
14 Oct 25

Result of Placing and Notice of GM

THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY.
RNS 9169429 ↗
13 Oct 25

Proposed Placing and Retail Offer

ZEUS CAPITAL LIMITED ("ZEUS"), WHICH IS AUTHORISED AND REGULATED IN THE UNITED KINGDOM BY THE FINANCIAL CONDUCT AUTHORITY, IS ACTING FOR THE COMPANY AND FOR NO-ONE ELSE IN CONNECTION WITH THE PLACING, AND ZEUS WILL NOT BE RESPONSIBLE TO ANYONE OTHER THAN...
RNS 9168156 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.